A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2011
10/26/2011	EP2379077A2 Pharmaceutical composition
10/26/2011	EP2379059A1 Controlled releasing composition
10/26/2011	EP2378872A1 Acne vulgaris treatment regimen
10/26/2011	EP2167069B1 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
10/26/2011	EP2083267B1 Diagnosis and treatment of autism using cd38
10/26/2011	EP2061452B1 Anti cancer use of caffeic acid and derivatives
10/26/2011	EP1631293B1 Compounds, formulations, and methods for treating or preventing rosacea
10/26/2011	EP1587477B1 Odorless formulation for treating mucosal discontinuities
10/26/2011	EP1429729B1 Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin
10/26/2011	EP1427837B1 Modular transfection systems based on nucleoprotein filaments
10/26/2011	CN102227227A Pharmaceutical combination comprising hsp90 and her2 inhibitors derived from pyridino-[4, 3-d]pyrimidine
10/26/2011	CN102227221A Pharmaceutical combination containing hsp90 inhibitor and mtor inhibitor
10/26/2011	CN102225203A Pharmaceutical composition used for lowering blood pressure
10/26/2011	CN102225202A Compound preparation containing aspirin and proton pump inhibitor
10/26/2011	CN102225201A New application of glycolytic inhibitor
10/26/2011	CN102225200A Methods and compositions for modulating TWEAK and FN14 activity
10/25/2011	US8044018 Reagents and methods for smooth muscle therapies
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043806 Method of diagnosing an RTK-hyperfunction induced disorder
10/25/2011	US8043628 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
10/25/2011	US8043614 Autogenic living scaffolds and living tissue matrices: methods and uses thereof
10/25/2011	US8043612 Infection and treatment of neoplasms with vesicular stomatitis virus
10/25/2011	CA2484020C Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/25/2011	CA2445612C Methods and compositions for treating mammalian nerve tissue injuries
10/25/2011	CA2437866C Novel clock gene bmal2
10/25/2011	CA2399865C Novel scavenger receptor
10/25/2011	CA2366277C Grb7 family proteins and the insulin receptor for screening new medications
10/25/2011	CA2330131C Method for the treatment of fertility disorders
10/20/2011	WO2011130232A1 Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor and an mtor inhibitor for treating cancer
10/20/2011	WO2011129427A1 Diagnostic agent and therapeutic agent for cancer
10/20/2011	WO2011128896A1 Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders
10/20/2011	WO2011128745A2 Fully openable multifunction drawer for household appliances
10/20/2011	WO2011128628A2 Gelled oral pharmaceutical compositions
10/20/2011	WO2011128625A2 Divisible oral pharmaceutical compositions
10/20/2011	WO2011128436A1 Combination of hypoxia-inducible factor-1 inhibitors and toll-like receptor-3 agonists for treating solid tumors
10/20/2011	WO2011128434A2 Treatment of endocrine resistant breast cancer
10/20/2011	WO2011128424A1 Methods and compositions for improving implant osseointegration
10/20/2011	WO2011128407A2 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations
10/20/2011	US20110257229 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/20/2011	US20110257227 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
10/20/2011	US20110256612 Compositions for culturing spirochetes
10/20/2011	US20110256240 Combination Therapy
10/20/2011	US20110256226 Opioid agonist formulations with releasable and sequestered antagonist
10/20/2011	US20110256223 Gastric retained gabapentin dosage form
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	DE102010022367A1 Pharmaceutical composition in form of lubricating agent or gel used for treating and preventing infections and pain associated with catheterization comprises octenidine or its salts and local anesthetic
10/20/2011	CA2800327A1 Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase 6 (cdk4/6) inhibitor and an mtor inhibitor for treating cancer
10/20/2011	CA2796253A1 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline-containing combinations
10/20/2011	CA2795886A1 Methods and compositions for improving implant osseointegration
10/19/2011	EP2377557A2 Compositions comprising azelastine and methods of use thereof
10/19/2011	EP2377541A1 Use of chitosans to increase nail growth rate
10/19/2011	EP2377531A2 Neurogenesis by modulating angiotensin
10/19/2011	EP2377530A2 Modulation of neurogenesis by PDE inhibition
10/19/2011	EP2376494A1 Dihydropyrimidopyrimidine derivatives
10/19/2011	EP2376092A2 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
10/19/2011	EP2376087A1 Erbb-3 (her3)-selective combination therapy
10/19/2011	EP2376078A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
10/19/2011	EP2363142A9 Elastase for opening obstructed biological conduits
10/19/2011	EP2162125B1 Composition for rectal administration combined with an oral alpha-lipoic acid composition for the treatment of inflammatory bowel disease
10/19/2011	EP1782831B1 External preparation
10/19/2011	EP1762610B1 Truncated dance, dance complex and method of using these
10/19/2011	EP1595936B1 Composition for external use
10/19/2011	EP1499321B1 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect")
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1405560B1 Il-18 transgenic animal
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1173197B2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
10/19/2011	CN1496404B Materials and methods relating to protein aggregation in neurodegenerative disease
10/19/2011	CN102220423A Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/19/2011	CN102219850A New long-acting GLP-1 (glucagonlike peptide-1) compounds
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218143A Water dispersion type carbon nano-tube freeze-dried powder and preparation method thereof
10/19/2011	CN102218142A Method for enhancing bacteriostatic effect of deep fungal-infection resistant antifungal medicament
10/19/2011	CN102218141A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
10/19/2011	CN102218140A Tumor resistance effect of medicine combination of salvianolic acid B and coxib medicaments
10/19/2011	CN102218027A Polymer micelle lyophilized agent encapsulating insoluble antitumor drug
10/19/2011	CN102217980A Preparation method for rhesus monkey choroids angiogenesis models
10/19/2011	CN101695476B Method for preparing medical nanoparticles
10/19/2011	CN101528215B Compositions of chk1 inhibitors and cyclodextrin
10/18/2011	US8039508 Obesity therapy; mixture of lipase inhibitor orlistat and sucrose fatty acid ester
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	US8039257 Pre-transplant accomodated organs resistant to anti-donor immunity
10/18/2011	US8039209 Yeast screens for treatment of human disease
10/18/2011	US8039026 Methods for treating skin pigmentation
10/18/2011	CA2673449C A combination comprising combretastatin and anticancer agents
10/18/2011	CA2494297C Aqueous 2,6-diisopropylphenol pharmaceutical compositions
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2480438C Novel use of the extract of processed ginseng and saponin isolated therefrom
10/18/2011	CA2466906C Pharmaceutical composition comprising a prostaglandin e1
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents
10/18/2011	CA2434927C Pharmaceutical compositions with antibiotic activity
10/18/2011	CA2433495C Methods of examining ability to control nerve cell plasticity
10/18/2011	CA2403218C Embolic compositions
10/18/2011	CA2213833C Vascular endothelial cell growth factor antagonists
10/13/2011	WO2011127325A1 Selection and use of host cells for production of glycoproteins
10/13/2011	WO2011127070A2 IRE-1α INHIBITORS
10/13/2011	WO2011126352A2 Anti-tuberculosis preparation based on an inclusion complex of cyclodextrin with rifampicin and a method for the preparation thereof
10/13/2011	WO2011126126A1 NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF
10/13/2011	WO2011126071A1 Agent for inhibiting viral infection and/or treating infectious disease, and method for inhibiting viral infection and/or treating infectious disease

1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 1151